Characterization of circRNAs in established osimertinib-resistant non-small cell lung cancer cell lines

Drug resistance is an urgent problem to be solved in the treatment of non-small-cell lung cancer (NSCLC). Osimertinib is a third-generation EGFR-tyrosine kinase inhibitor, which can improve the efficacy and quality of life of patients; however, the inevitable resistance after long-term use of osimer...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xin, Gu, Jingyao, Huang, Jiali, Wen, Kang, Zhang, Ge, Chen, Zhenyao, Wang, Zhaoxia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619537/
https://www.ncbi.nlm.nih.gov/pubmed/37681495
http://dx.doi.org/10.3892/ijmm.2023.5305

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619537/
https://www.ncbi.nlm.nih.gov/pubmed/37681495
http://dx.doi.org/10.3892/ijmm.2023.5305

Ejemplares similares